164
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Pretreatment Neutrophil-to-Lymphocyte Ratio as Prognostic Biomarkers in Patients with Unresectable Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab

ORCID Icon, , , ORCID Icon, ORCID Icon, , , & show all
Pages 2049-2058 | Received 24 Jul 2023, Accepted 02 Nov 2023, Published online: 08 Nov 2023